Coronary artery disease trials in Australia

In Australia 25 Also abroad 1309

25 trials · From ClinicalTrials.gov, checked 10 November 2026. Ask the study team whether a trial fits you.

Phase 2Taking people
A Phase 2b Clinical Trial of YN001 in Adults With Coronary Atherosclerosis
Where
Altona N., Brisbane, Penrith
Age
18 years to 80 years
People
456 worldwide
Run by
Beijing Inno Medicine Co., Ltd.
See details and how to joinNCT07521007
Phase 2Taking people
Prevention of Reperfusion Injury Outcomes Through Effective Cardioprotection Targeting Myocardial Infarction
Where
Adelaide, Epping, Frankston, Kingswood, Liverpool, Nedlands, Perth, Saint Albans
Age
40 years to 75 years
People
300
Run by
Nyrada Pty Ltd
See details and how to joinNCT07362446
No phaseTaking people
AVS Pulse Intravascular Lithotripsy™ (Pulse IVL™) to Open Vessels With Calcific Walls and Enhance Vascular Compliance and Remodeling for Coronary Artery Disease
Where
Melbourne, Sydney
Age
18 years and over
People
15 worldwide
Run by
Amplitude Vascular Systems, Inc.
See details and how to joinNCT07510438
Phase 1/2Not yet taking people in Australia
EDIT-401 in Adults Who Require Additional Lowering of Low-Density Lipoprotein Cholesterol (LDL-C)
Where
Charlestown, Perth
Age
18 years to 65 years
People
56
Run by
Editas Medicine, Inc.
See details and how to joinNCT07894887
No phaseTaking people
Product Surveillance Registry
Where
Chermside, Murdoch, Southport, Westmead
People
100,000 worldwide
Run by
Medtronic
See details and how to joinNCT01524276
No phaseTaking people
AGENT DCB STANCE: Safety and Effectiveness Study of AGENT Drug-Coated Balloon Compared to Standard of Care Percutaneous Coronary Intervention (PCI) Treatment for de Novo Coronary Lesions
Where
Chermside, Clayton
Age
18 years and over
People
1,616 worldwide
Run by
Boston Scientific Corporation
See details and how to joinNCT06959524
Phase 2Taking people
Dose-finding Study of YMI024 to Assess Efficacy, Safety, and Tolerability in Adults With Stable Coronary Artery Disease and Elevated hsCRP
Where
Adelaide, Frankston, Melbourne, Mulgrave
Age
18 years to 80 years
People
180 worldwide
Run by
Novartis Pharmaceuticals
See details and how to joinNCT07830719 · EU 2026-525974-21-00
No phaseTaking people
Abbott Vascular Medical Device Registry
Where
Nedlands
Age
18 years and over
People
3,784 worldwide
Run by
Abbott Medical Devices
See details and how to joinNCT04573660
No phaseTaking people
Guideline Oriented Approach To Lipid Lowering In Asia-Pacific
Where
Bedford Park, Cairns, Clayton, Melbourne, Wollongong
Age
18 years and over
People
2,000 worldwide
Run by
Stephen Nicholls
See details and how to joinNCT05325034
Phase 3Taking people
Low Dose ColchicinE in pAtients With Peripheral Artery DiseasE to Address Residual Vascular Risk
Where
Box Hill, Perth
Age
18 years and over
People
6,150 worldwide
Run by
Population Health Research Institute
See details and how to joinNCT04774159
Early phase 1Taking people
Placebo-controlled Study of Single and Multiple Ascending Doses of UDP-003 in Healthy Human Participants and Followed by an Open-label Patient Cohort
Where
Adelaide, Camberwell, Melbourne
Age
18 years to 79 years
People
84
Run by
Cyclarity Therapeutics, Inc.
See details and how to joinNCT06813339
Phase 2/3Taking people
Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)
Where
Bundaberg, Cairns, Clayton, Heidelberg, Liverpool, Murdoch, Nambour, Parkville, Saint Leonards, Southport, St Albans, Sydney, Urraween, Wahroonga, Westmead, Wollongong, Woolloongabba
Age
18 years and over
People
3,110 worldwide
Run by
CSL Behring
See details and how to joinNCT05485961 · EU 2022-500273-14-00
Phase 1Taking people
A Study of STX-1150 in Participants With Elevated Low-Density Lipoprotein Cholesterol (LDL-C)
Where
Clayton
Age
18 years to 70 years
People
64 worldwide
Run by
Monash University
See details and how to joinNCT07428473
Phase 3Taking people
Evaluation of Efficacy and Safety of Early in Hospital Initiation of Inclisiran Treatment in Patients With Acute Coronary Syndromes
Where
Clayton, Garran
Age
18 years and over
People
300 worldwide
Run by
Novartis Pharmaceuticals
See details and how to joinNCT07102628
Phase 1Taking people
A Study of VERVE-102 in Patients With Familial Hypercholesterolemia or Premature Coronary Artery Disease
Where
Adelaide, Melbourne, Sydney
Age
18 years to 70 years
People
85 worldwide
Run by
Verve Therapeutics, Inc.
See details and how to joinNCT06164730
Phase 3Taking people
OCEAN(a)-PreEvent - Olpasiran Trials of Cardiovascular Events And LipoproteiN(a) Reduction to Prevent First Major Cardiovascular Events
Where
Auchenflower, Bedford Park, Camperdown, Charlestown, Clayton, Concord, Garran, Greenfields, Joondalup, Leabrook, Melbourne, Merewether, Milton, Nedlands, Norwood, Orange, Perth, Sippy Downs, Wollongong, Woolloongabba
Age
50 years to 105 years
People
11,000 worldwide
Run by
Amgen
See details and how to joinNCT07136012
No phaseTaking people
Diabetes-Centered Evaluation of Revascularization Strategy of Functional and Imaging-CombiNEd State-of-the-Art Percutaneous Coronary Intervention or Coronary-Artery Bypass Grafting in Patients With Diabetes Mellitus and Multivessel Coronary Artery Disease
Where
Clayton
Age
20 years and over
People
1,500 worldwide
Run by
Duk-Woo Park, MD
See details and how to joinNCT05831085
No phaseTaking people
Comparison of the Outcomes of Single vs Multiple Arterial Grafts in Women
Where
Clayton, Melbourne
Age
18 years and over
People
2,300 worldwide
Run by
Weill Medical College of Cornell University
See details and how to joinNCT04124120
Phase 2Not yet taking people in Australia
Safety and Efficacy of MiSaver (CB Cells) for Acute Myocardial Infarction, Phase II
Where
Bedford Park
Age
45 years and over
People
102 worldwide
Run by
HONYA Medical Co Ltd
See details and how to joinNCT07134712
No phaseTaking people
Risk-guided Disease managEment Plan to prevEnt CAD in Patients Treated With Previous Cancer
Where
Hobart, Melbourne
Age
40 years to 70 years
People
748
Run by
Baker Heart and Diabetes Institute
See details and how to joinNCT05366153
No phaseTaking people
Resorbable Magnesium Scaffolds Registry
Where
Cairns
Age
18 years and over
People
1,106 worldwide
Run by
Biotronik AG
See details and how to joinNCT04679740
Phase 2Not yet taking people in Australia
The Anti-Anginal Effects of N-Acetylcysteine (NAC) in Patients with Angina and Non-Obstructive Coronary Arteries (ANOCA)
Where
Adelaide
Age
18 years and over
People
25
Run by
University of Adelaide
See details and how to joinNCT06890507
No phaseEnrolling by invitation
Distal Evaluation of Functional Performance with Intravascular Sensors to Assess the Narrowing Effect: Guided Physiologic Stenting
Where
Gateshead, Gosford, Liverpool, Melbourne, Saint Leonards, Sydney
Age
18 years and over
People
3,212 worldwide
Run by
Philips Clinical & Medical Affairs Global
See details and how to joinNCT04451044
Phase 3Taking people
A Study of Low-dose Intracoronary Thrombolytic Therapy in STEMI (Heart Attack) Patients.
Where
Adelaide, Bankstown, Box Hill, Camperdown, Clayton, Concord, Elizabeth Vale, Epping, Frankston, Frenchs Forest, Liverpool, Murdoch, New Lambton Heights, Perth, Randwick, Saint Albans, Wollongong
Age
18 years and over
People
445 worldwide
Run by
University of Sydney
See details and how to joinNCT03998319
No phaseTaking people
Programmed Ventricular Stimulation to Risk Stratify for Early Cardioverter-Defibrillator (ICD) Implantation to Prevent Tachyarrhythmias Following Acute Myocardial Infarction (PROTECT-ICD)
Where
Birtinya, Cairns, Chermside, Clayton, Douglas, Elizabeth Vale, Epping, Garran, Herston, Kingswood, Melbourne, New Lambton Heights, Randwick, Saint Leonards, Southport, Westmead, Wollongong, Woolloongabba
Age
18 years to 85 years
People
1,058 worldwide
Run by
Western Sydney Local Health District
See details and how to joinNCT03588286